Dishman Carbogen Amcis Limited (DCAL.BO)
Dishman Carbogen Amcis Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Ahmedabad, GU, IN. The stock last traded at $190.40, down 4.08% on the session, giving a market capitalisation of $29.93B. Its beta of 0.62 implies it has historically moved less than the broad market.
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited delivers contract research and manufacturing solutions to the global and Indian pharmaceutical sectors. The company's activities are structured across two principal segments: Contract Research and Manufacturing Services, and Marketable Molecules. Its comprehensive product range encompasses the production and distribution of bulk drugs, active pharmaceutical ingredients (APIs), including both generic and highly potent varieties. Furthermore, it supplies specialized chemical compounds such as phase transfer catalysts, quaternary ammonium compounds, phosphoranes, and Wittig reagents, alongside a variety of vitamin D products and their analogues, cholesterol, lanolin-derived products, and other fine chemicals. Dishman Carbogen Amcis also offers consumer-oriented items like hand and body wash, sanitizers, antiseptics, and various disinfectant formulations, in addition to diverse pharmaceutical and cosmetic goods. Dishman Carbogen Amcis Limited functions as a subsidiary of Adimans Technologies LLP.
Dishman Carbogen Amcis Limited is most often compared with the following Healthcare names: